Latest News
Conference Coverage
Does exposure to cell phone Wi-Fi spell trouble for sperm?
Preliminary study hints that motility, viability could take a hit when devices are in pockets.
Conference Coverage
Stopping levothyroxine in subclinical hypothyroidism safe, feasible
Despite apparent lack of benefits, many still receive levothyroxine for subclinical hypothyroidism.
From the Journals
Goodbye ‘diabetes insipidus’, hello ‘AVP-D’ and ‘AVP-R’
Confusion with the term ‘diabetes mellitus’ ... has spurred proposed name change by an international panel representing major endocrinology...
Conference Coverage
Achieving diversity, equity and inclusion: Invite everyone and build a team
Don’t recruit diverse people to your program and then have them come and feel not included.
From the Journals
Few transgender teens discontinue hormones in young adulthood
Pioneering clinic’s research finds that 98% of transgender adolescents taking puberty blockers and cross-sex hormones were still taking the latter...
Conference Coverage
Don’t be afraid of weight gain with hyperthyroid treatment
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.
From the Journals
Yoga and other mind-body work good for diabetes control
Mind-body practices can control fasting blood glucose and A1c to a clinically significant extent, thus offering an effective complementary...
Conference Coverage
Drug repurposing ‘fast track’ to new medicines for obesity, diabetes
“We would like to progress some of these compounds to preclinical and clinical trials, but need to raise the funds for this expensive research.”...
Guidelines
New AGA guidelines advise use of antiobesity medications for weight management
Though lifestyle interventions are the first-line treatment for overweight and obesity, use of specific pharmacological agents should be...
Conference Coverage
Nonhormonal drug fezolinetant found safe for hot flashes in yearlong study
Although additional safety studies await fezolinetant before it heads to the FDA for approval, it appears to be on its way to offering women an...
From the Journals
Islet transplants in type 1 diabetes durable up to 8 years
Long-term insulin independence and safety is seen with islet-cell transplant in patients with severe hypoglycemia at baseline.